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Abstract
Objective—To study the impact of implementing a protocol to standardize the duration of 
observation in preterm infants with apnea/bradycardia/desaturation spells before hospital discharge 
on readmission rates and length of stay (LOS).
Study design—A protocol to standardize the duration of in-hospital observation for preterm 
infants with apnea, bradycardia and desaturation spells who were otherwise ready for discharge 
was implemented in December 2013. We evaluated the impact of this protocol on the LOS and 
readmission rates of very low birth weight infants (VLBW). Data on readmission for apnea and 
apparent life-threatening event (ALTE) within 30 days of discharge were collected. The pre-
implementation epoch (2011-2013) was compared to the post-implementation period (2014-2016).
Results—There were 426 and 368 VLBW discharges before and after initiation of the protocol 
during 2011-2013 and 2014-2016 respectively. The LOS did not change with protocol 
implementation (66±42 vs. 64±42 days before and after implementation of the protocol 
respectively). Inter-provider variability on the duration of observation for apneic spells (F-8.8, 
p=0.04) and bradycardia spells (F-17.4, p<0.001) decreased after implementation of the protocol. 
The readmission rate for apnea/ALTE after protocol decreased from 12.1% to 3.4% (p=0.01).
Conclusions—Implementing an institutional protocol for VLBW infants to determine the 
duration of apnea/ bradycardia/ desaturation spell-free observation period as recommended by 
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American Academy of Pediatrics clinical report did not prolong the LOS but effectively reduced 
inter-provider variability and readmission rates.
Keywords
Apnea; length of stay; apparent life-threatening event (ALTE); readmission; bronchopulmonary 
dysplasia (BPD)
Introduction
Apnea of prematurity is a common problem in the neonatal intensive care unit (NICU). It is 
most widely defined as cessation of breathing for more than 20 seconds or a shorter 
respiratory pause associated with oxygen desaturation and/or bradycardia in infants who are 
younger than 37 weeks’ postmenstrual age (PMA) at birth 1. Apnea occurs in almost all 
babies born less than 28 weeks’ PMA, and the frequency of symptoms are inversely 
proportional to PMA 2, 3. The management strategies currently available for these infants 
include respiratory support, caffeine and continuous monitoring of heart rate, respiratory 
rate, and oxygen saturation 4, 5. Management practices surrounding discharge decisions for 
infants with spells vary widely among neonatologists 6, 7. Most physicians require infants to 
be apnea/bradycardia event free and off caffeine for a variable period before discharge. The 
Clinical Report from the American Academy of Pediatrics (AAP) Committee on Fetus and 
Newborn (COFN) 1 states that a clinically significant apnea event-free period before 
discharge of 5 to 7 days is commonly used. This report also suggests that individual NICUs 
should develop their own protocols for management of preterm infants with such spells 
before discharge. Darnall et al. 6 reported that cessation of apnea was an important factor 
that determined discharge. These authors reported physician variability and concluded that 
the margin of safety period for apneic spell-free period before discharge to be eight days (in 
the absence of other comorbidities). Another large study involving 1403 infants by Lorch et 
al. reported the effect of observing the infants for different apnea/bradycardia spell free 
periods before discharge and their success rates for not having additional spells. The success 
rate in this large cohort of preterm infants who were observed for a 7-day apnea/bradycardia 
free period was 95% 8. In our institution, our period of observation before discharge varied 
widely among physician providers. We developed a standard protocol to determine the 
duration of observation in the hospital based on the nature and severity of apnea, bradycardia 
and/or desaturation. We report the impact of implementing this protocol on the length of stay 
(LOS), inter-provider variance in the duration of observation and readmission rates at our 
regional perinatal center.
Methods
Definitions
For the purpose of this protocol, the following definitions were established. Apnea was 
defined as cessation of breathing for a duration of ≥ 15 seconds (following a 5-second delay 
in alarm triggering). Bradycardia was defined as a drop in heart rate of < 80/minute and 
desaturations as a drop in oxygen saturation < 85%. The duration of isolated bradycardia and 
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desaturation was ≥ 10 seconds but this period varied based on associated events such as 
color change and rapidity of decline in heart rate and oxygen saturation.
Observation
Our current NICU is an open 6-8 bed pods and the infants at the time of observation of 
spells before discharge are either in an open crib or bassinet. The parents are encouraged to 
feed their babies and room in, especially if they are being discharged on oxygen or on an 
apnea monitor. A nurse is always at the bedside or in the room, and only the observed events 
were recorded. We did not use telemetry waveforms to review the events later. Infants in our 
NICU were monitored on both cardiorespiratory monitor and pulse oximetry until hospital 
discharge. The monitors we use in our NICU are Phillips IntelliVue MX800 (N.V. USA). It 
provides continuous oxycardiogram (OxyCRG) with beat-to-beat heart rate (btbHR), an 
oxygenation measurement trend (SpO2) and compressed respiration wave. 
Electrocardiogram output uses an impedance of <2.5KΩ±20%. Our cardiorespiratory 
monitor immediately alarms for bradycardia and desaturation as soon as the values declines 
below the defined cut-off. The alarm has a 5-second delay for apnea. So if the baby was 
apneic for 10 seconds after the alarm, the total duration was 15 seconds (10+5 seconds). The 
bradycardia detection is beat-to-beat according to the monitor specification for neonates, and 
the alarm goes on displaying heart rate averaged over 3 seconds.
Record of events
Spells have been routinely recorded in the electronic medical record since 2011. For each 
event, a ‘yes’ or ‘no’ is documented for apnea, bradycardia, and desaturation. In addition to 
the duration of the event in seconds, the absolute lowest heart rate (beats per minute) and 
lowest saturation (percentage) are also recorded. All available events had a heart rate and 
saturation recorded. If apnea was present, this duration was recorded. The EMR system 
would not allow recording an event without this information. The spells recorded were based 
on nursing documentation and not based on reviewing telemetry 9, 10.
Protocol development
Available data from previous studies and consensus statements were reviewed 6-8, 11.
Protocol (figure 1)
Based on the above review of literature and consensus among the physicians, mid-level 
providers and nurses, we implemented the protocol shown in figure 1. This figure depicts the 
period of observation before hospital discharge for spells of varying severity. Spells 
associated with feeds that resolved when the nipple was taken out of the mouth were not 
considered significant 12, 13.
Implementation
The protocol was incorporated into our institutional policy following approval by neonatal 
physicians and providers. The protocol was loaded on the digital documentation software, 
Neodata (Isoprime, Chicago, IL) which could be accessed by all neonatal providers. The 
protocol was implemented in late December 2013 as our standard of care following three 
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months of nursing education. In assessing compliance with the protocol, the events were 
reviewed during daily morning rounds with the bedside nurse and resident/practitioner. The 
nursing manager and leader had frequent interactions with the nurses to review compliance.
Data collection
After approval by the Institutional Review Board (University at Buffalo), premature infants 
<1500 grams who were admitted &discharged from the NICU during the study period were 
included. The study period was divided into two epochs 2011-2013 and 2014-2016. 
Demographic information including birth weight, gestational age, sex, inborn/outborn status, 
growth and Apgar scores at 5 minutes was collected. The number of infants admitted in a 
particular year and discharged each year (from January 1 – December 31) were collected 
separately. The incidence of bronchopulmonary dysplasia (BPD - defined as oxygen 
requirement at 36 weeks PMA), severe IVH (≥ grade 3), and mortality before discharge 
were recorded. The number of infants discharged home with apnea monitors was collected. 
The infants who required home oxygen were discharged with an apnea monitor. Also, 
parents who specifically requested apnea monitors were counseled on the literature (or lack 
thereof) supporting the use of monitors for apnea of prematurity 14. If parents continued to 
insist, these infants were sent home on apnea monitors. The overall LOS for all infants 
discharged between 2011 and 2016 was collected. The duration of in-hospital observation 
for VLBW infants whose discharges were delayed due to spells was compared between the 
two epochs. We screened all patients presenting to the ED and/or admitted for any reason 
within 30 days of discharge and evaluated all those with complaints of apnea and/or 
apparent life-threatening event (ALTE) for this assessment. The readmission rates were 
calculated as a percentage of VLBW infants discharged from the NICU in that particular 
year. Women and Children’s Hospital of Buffalo is a regional referral center of Western New 
York and is the only provider of pediatric inpatient/critical care in the region. Any pediatric 
patient presenting to an emergency department or urgent care facility with complaints of 
apnea/ALTE is transferred to our institution.
Statistics
Categorical variables are presented as numbers and percentage, while continuous variables 
are presented as a mean and standard deviation (S.D) or median and interquartile range 
(IQR) as applicable. The Chi-square test analyzed categorical variables. For parametric and 
nonparametric continuous variables, the analysis was performed by unpaired t-test and 
Mann-Whitney U test respectively. Multivariate analysis for interactions with LOS and 
ANOVA with post hoc analysis was conducted to compare groups. Variance between the 
spell-free observation periods before and after implementing the protocol was compared and 
analyzed by the F test. A probability of less than five percent was considered significant.
Results
Admissions
There were 752 VLBW infants admitted to the NICU at Women and Children’s Hospital of 
Buffalo during 2011 and 2016. Table 1 shows the admission characteristics of these infants. 
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There were no significant differences in any of the baseline characteristics during this 
period.
Discharges
731 VLBW infants were discharged during this period. Table 2 shows the discharge 
characteristics. There were 426 and 368 discharges before and after initiation of the protocol 
respectively. The PMA at discharge did not differ in the two epochs (37.4±5.6 vs. 37.3±5.8 
weeks). There was no difference in the number of infants who were discharged home on an 
apnea monitor. The discharges were more than the admissions secondary to the infants 
admitted in the previous year being discharged the next year.
Observation period just before discharge (figure 2)
Between 2011 and 2016, 268 VLBW infants were observed on a “spell-watch” when they 
were otherwise ready for discharge. The percentage of infants observed during the two 
epochs before and after protocol implementation - 157/426 (37%) vs. 111/368 (30%) 
respectively were not different (p=0.05). The spells were classified into apneic spells (with 
or without bradycardia) and bradycardic spells without apnea. The number of infants and the 
delay in discharge due to spells in each of these categories is shown in figure 2.
The implementation of the protocol did significantly change the duration of observation 
secondary to apneic spells and bradycardia spells following protocol implementation (figure 
2).
i. Apneic spells requiring stimulation: Out of 426 infants discharged between 2011 
and 2013, 42 (10%) infants were observed on an apnea (with or without 
bradycardia) spell count for 8 (6-10) days. During the 2014-16 epoch, 32 out of 
368 infants (9%) were observed on an “apnea spell watch” for 7 (6-8) days. The 
duration of observation for apneic spells significantly decreased following 
implementation of the protocol (F=8.8, p=0.04).
ii. Self-resolved apnea, without bradycardia (HR<85/m) and without desaturations 
(<85%) and no color change: Twenty infants (5%) were observed for a 5-day 
period between 2014-2016. No comparison was made before the implementation 
of the protocol.
iii. Bradycardic spells: 115 (27%) infants were on an isolated “bradycardia (without 
apnea) spell watch” for 6 (5-9) days before discharge in the period before 
implementation of the protocol. 79 (21%) infants had isolated “bradycardia spell 
watch” observation for 5 (5-7) days before discharge after the implementation of 
the protocol. The duration for observing preterm infants with isolated 
bradycardia significantly decreased (F=17.4, p<0.001) after implementation of 
the protocol.
iv. Isolated bradycardia or isolated desaturations: 17 (5%) infants between 
2014-2016 were observed for isolated desaturations for an average of 3 days. We 
did not have a comparison group before the implementation of the protocol.
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The length of stay (LOS) of all infants discharged (figure 3a)
The LOS before and after implementation of the protocol for all VLBW infants was 66±42 
vs. 64±42 days. LOS in infants discharged immediately after completion of their spell-count 
(157 vs. 111 infants before and after implementation of the protocol respectively) was not 
different (71.3±33.8 vs. 66.4±30.4 days, p=0.22). A multivariate analysis looking at the 
factors affecting LOS showed gestational age (R squared 0.549), birth weight (R squared 
0.493) and comorbidities such as BPD & IVH grade III or above (R squared 0.534) affected 
the LOS (p<0.001). Further analysis of LOS by 3 categories of birth weight ≤ 750 g (97±56 
days), 751-1000g (85±32 days) and >1000g (52±26 days) by ANOVA was significantly 
different (p<0.006).
Readmission rates
Readmission rates for apnea/ALTE within 30 days of discharge: Readmission as a 
percentage of discharges is shown in figure 3b. The readmission rates before and after 
implementation of the protocol were 12.9% vs. 3.4% respectively (p=0.0134). The 
characteristics of infants readmitted are shown as a table (Supplementary – Table 1). We did 
not have any readmission for apnea/ALTE for VLBW infants discharged in 2016.
Discussion
To our knowledge, this is one of the largest studies to evaluate the impact of implementing a 
standardized protocol for the duration of observation in infants with apnea/bradycardia 
spells before discharge. The recent recommendations by Eichenwald et al. on behalf of the 
AAP COFN 1 highlight the lack of consistent definitions and consensus in the management 
of apnea and discuss variations in practice. This clinical report encourages the development 
of institutional protocols to address the approach to discharge in infants with apnea of 
prematurity. Our protocol emphasizes the use of standard definitions and observation periods 
in infants with apnea of prematurity. There are studies to suggest 7, 8 that spell-free 
observation period before discharge need not be uniform and modified durations can be 
considered for preterm infants based on gestational age at birth. In a tertiary regional 
perinatal center with a large practice group consisting of neonatologists, fellows, residents 
and practitioners the standardized approach implemented in our institution had to be specific 
but simple. Hence standard duration of observation depending on the type of spell was 
followed for all preterm infants irrespective of gestational age at birth.
A recent study which looked at the effect of standardizing the definition and management of 
apnea of prematurity reduced caffeine use and decreased the number of infants discharged 
on a monitor 15. With the implementation of our standard protocol, we saw a modest 
reduction in the number of infants placed on a “spell-watch” just before discharge from 40% 
to 33% (not significant). Our admissions and discharges during this timeframe were fairly 
consistent. There were no differences in caffeine use and rates of BPD during the period of 
the study although the use of the high-flow nasal cannula and noninvasive ventilation 
increased in our NICU 16. We believe this reduction may be secondary to standard 
definitions of a spell which was easily available for reference to the nurses.
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The main purpose of implementing this protocol was to standardize the approach to spells 
before discharge and to reduce inter-provider variability. We achieved this goal with this 
protocol in our NICU. In a regional perinatal center involving thirteen neonatologists, fifteen 
practitioners, six fellows with two new incoming fellows every year, there existed 
considerable variations in our practice. Apneic spells were commonly observed for a spell 
free period of one week and off caffeine before discharge with some providers monitoring 
the infants as long as ten days. Isolated bradycardia without apnea is often the last event to 
resolve among preterm infants and is of uncertain clinical significance 1, 17. There was 
considerable variation in observing an infant with isolated bradycardia before 
implementation of the protocol (Figure 2). Following the implementation of the protocol, the 
variability among providers to monitor for an apneic episode and isolated bradycardic 
episode significantly decreased. We did not have any specific measures to quantify 
adherence to the protocol by physicians, practitioners and nurses. With the reduction in 
inter-provider variability, it is safe to assume that we adhered to the protocol with some 
variation.
Butler et al. showed that implementation of a standard approach to apnea of prematurity 
decreased the LOS, cost and reduced readmission rates 18. This study included infants who 
were between 29 and 34 weeks PMA at birth without continuous positive airway pressure 
requirement in the delivery room with short pre- and post-standardization epochs (1 year 
each) compared to our study. In our unit, the overall LOS of all VLBW infants discharged 
during the two epochs did not change significantly after implementing the standard protocol. 
The LOS of VLBW infants who were observed for spells immediately before discharge 
between the two epochs slightly decreased but this reduction was not statistically significant 
(LOS in infants discharged immediately after completion of their spell-count 157 vs. 111 
infants before and after implementation of the protocol respectively slightly decreased was 
not different (71.3±33.8 vs. 66.4±30.4 days, p=0.22)). Further analysis of our data suggested 
that gestational age, birth weight, BPD and IVH grade 3 & above had interaction and 
affected the LOS. This finding is in accordance with the previous studies which have 
evaluated the prominent role of PMA at birth, birth weight and other co-morbidities in 
determining LOS 6, 11, 19,20-23. We speculate that continued observation and collecting data 
from multiple centers may result in a higher ‘n’ and may show a significant reduction in 
LOS.
Our unit observes infants on cardiorespiratory and pulse oximetry monitors until the time of 
discharge. Although our protocol included a 3-day observation for isolated desaturations 
without apnea or bradycardia, these episodes were usually associated with misplaced home 
oxygen nasal cannula in infants with BPD or with feeds 12, 13, 24, 25. This was not studied in 
detail as considerable variation existed in the documentation of isolated desaturations in the 
two epochs. Some NICUs in their step-down unit or convalescent nursery take patients off 
pulse oximetry monitors before discharge. Such practice would not detect isolated 
desaturation episodes. The significance of isolated desaturations without apnea or 
bradycardia remains unclear and requires further evaluation 14, 26. A regional saturation 
(cerebral oximetry) monitor may give us further information about the isolated desaturations 
27
.
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We observed a significant decrease in readmission rates after implementation of a protocol 
for apnea/ALTE. In our study, the average age of VLBW infants at discharge was 38 weeks 
and the number of babies who were sent home on monitors did not differ between the two 
epochs. Infants who are discharged home on supplemental oxygen from our NICU are 
always sent home on apnea monitors. The number of infants discharged home on oxygen, 
and those who were sent home on monitors did not change during the study period (Table 2). 
Some studies have evaluated multiple factors affecting rehospitalization of preterm neonates. 
Among them, some of the key factors include insurance and socioeconomic status, BPD, 
acute respiratory infections and extreme prematurity, and RSV infection 28-33. We primarily 
looked at the readmission of infants ≤1500g with apnea and or ALTE. We did not have 
information on the insurance/socioeconomic status, environmental exposure, level of 
education of the parents, number of siblings at home, etc. All these factors can affect the risk 
of readmission. With the implementation of the protocol, we encouraged parents when 
infants were on spell-count to room in and feed these neonates in order to transition to the 
home environment. Parents were aware of the discharge criteria and the observation for a 
spell. Although we do not have a clear reason for the decrease in readmissions, we speculate 
that parental rooming in during the spell-watch educated them on handling these spells and 
enabled a smooth transition to home environment 34.
This study reflects the overall impact of implementing a standard protocol for observing 
infants with spells. The strength of the study is a large number of infants who were observed 
during the two epochs and the significant reduction in inter-provider variability and 
readmission rates after protocol implementation, especially in a large practice group. We 
have several limitations: The adherence to the protocol and variation in special scenarios 
such as isolated desaturation associated with color change were not studied in detail due to 
documentation variability among nurses. Although we had criteria for defining isolated 
bradycardia and desaturations, the duration of these episodes was based on consensus and 
not on scientific evidence. We also did not study the effects of blood transfusion 35. Nursing 
documentation of the desaturation episodes was variable and associated events such as a 
dislodged nasal cannula, reflux, etc., were not consistently recorded 24, 36. Although a 
regional perinatal center, it is still possible that few infants could have relocated and we may 
have lost them to follow up. It is also possible that shorter duration of observation (< 3-5 
days) – especially for isolated bradycardia spells and desaturation spells may be adequate 
and were not investigated in this study. Due to this, we have a revised version of the protocol 
as a supplemental figure (supplementary figure 1) and we intend to implement it. We will 
continue to review our practice with the protocols and once we move to our new children’s 
hospital (Oishei Children’s Hospital, November 2017) with single bed NICU’s, we will 
study the impact of our protocol and make necessary changes.
Conclusion
We conclude that, as recommended by AAP, implementing an institutional protocol to 
determine the duration of apnea/ bradycardia/ desaturation spell-free observation period did 
not prolong the LOS but effectively reduced readmission rates and inter-provider variability. 
Further large multicenter, prospective trials evaluating these protocols are required before 
widespread implementation in NICUs.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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ALTE apparent life-threatening event
LOS length of stay
PMA post menstrual age
VLBW very low birth weight infants
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Figure 1. 
The Protocol for determining the duration of “spell-free” observation period for a premature 
infant who is otherwise ready for discharge (on full enteral feeds, gaining weight and 
maintaining the temperature in a crib).
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Figure 2. 
Inter-provider variability before and after implementation of the protocol. *p<0.05 by F-test, 
between 2 epochs.
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Figure 3. 
a: Length of stay for all VLBW infants before and after implementation of the protocol 
(vertical arrow).
b: Readmission rates before and after implementation of the protocol. The median 
readmission rates were calculated between 2011-2013 (4.9%). The vertical arrow indicates 
the time of implementation of the protocol. The horizontal line with a *p-value (0.0134) 
shows the significance in readmission rate before (2011-2013) and after the protocol 
(2014-2016).
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